
ML192
CAS No. 460331-61-7
ML192( —— )
Catalog No. M34655 CAS No. 460331-61-7
ML192 (CID1434953) is a selective GPR55 ligand antagonist. ML192 is an inhibitor that inhibits β-arrestin transport, ERK1/2 phosphorylation, and PKCβII translocation.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 70 | Get Quote |
![]() ![]() |
5MG | 107 | Get Quote |
![]() ![]() |
10MG | 178 | Get Quote |
![]() ![]() |
25MG | 293 | Get Quote |
![]() ![]() |
50MG | 423 | Get Quote |
![]() ![]() |
100MG | 583 | Get Quote |
![]() ![]() |
500MG | 1161 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameML192
-
NoteResearch use only, not for human use.
-
Brief DescriptionML192 (CID1434953) is a selective GPR55 ligand antagonist. ML192 is an inhibitor that inhibits β-arrestin transport, ERK1/2 phosphorylation, and PKCβII translocation.
-
DescriptionML192 is a selective ligand antagonist of GPR55. ML192 inhibits the β-arrestin trafficking, ERK1/2 phosphorylation and PKCβII translocation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorArrestin | Cannabinoid Receptor | GPR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number460331-61-7
-
Formula Weight382.48
-
Molecular FormulaC20H22N4O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (261.45 mM; Ultrasonic )
-
SMILESCc1nc(N2CCN(CC2)C(=O)c2ccco2)c2c3CCCCc3sc2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kotsikorou E, et al. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands. Biochemistry. 2013 Dec 31;52(52):9456-69.?
molnova catalog



related products
-
Spiroxamine
Spiroxamine is a tertiary amine fungicide and an inhibitor of δ14 reductase and δ8→δ7 isomerase. Spiroxamine inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines.
-
Trioxsalen
Trioxsalen is a furanocoumarin and a psoralen derivative, in conjunction with UV-A for phototherapy treatment of vitiligo and hand eczema.
-
Carlinoside
Carlinoside could be a worthy choice to intervene hyperbilirubinemia due to liver dysfunction. Carlinoside upregulates Nrf2 gene expression, increases its nuclear translocation and stimulates UGT1A1 promoter activity.